Telemetry Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,743
| Closed | -$44K | – | 68 |
|
|
2019
Q2 | $44K | Sell |
1,743
-3,902
| -69% | -$98.5K | 0.03% | 65 |
|
|
2019
Q1 | $240K | Buy |
5,645
+4,968
| +734% | +$211K | 0.12% | 52 |
|
|
2018
Q4 | $10K | Sell |
677
-773
| -53% | -$11.4K | 0.01% | 98 |
|
|
2018
Q3 | $102K | Sell |
1,450
-1,144
| -44% | -$80.5K | 0.05% | 76 |
|
|
2018
Q2 | $192K | Sell |
2,594
-2,406
| -48% | -$178K | 0.07% | 91 |
|
|
2018
Q1 | $476K | Buy |
5,000
+622
| +14% | +$59.2K | 0.18% | 48 |
|
|
2017
Q4 | $565K | Sell |
4,378
-205
| -4% | -$26.5K | 0.22% | 36 |
|
|
2017
Q3 | $311K | Buy |
4,583
+1,050
| +30% | +$71.3K | 0.11% | 66 |
|
|
2017
Q2 | $334K | Buy |
3,533
+108
| +3% | +$10.2K | 0.16% | 59 |
|
|
2017
Q1 | $492K | Sell |
3,425
-27
| -0.8% | -$3.88K | 0.22% | 46 |
|
|
2016
Q4 | $437K | Buy |
+3,452
| New | +$437K | 0.25% | 43 |
|